All In Biotech

Free tool

FAERS Monitor: Myxredlin

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming BLA 208157 or its brand name (Myxredlin, Insulin Human). Reports on generic versions are filed under their own applications.

Reports

6,745

Serious

5,542

82% of reports

Hospitalization

3,116

Death reported

779

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • blood glucose increased966
  • hypoglycaemia434
  • drug ineffective380
  • dyspnoea331
  • hyperglycaemia329
  • diarrhoea325
  • blood glucose decreased295
  • off label use291
  • headache257
  • nausea250
  • fall246
  • weight decreased242
  • vomiting237
  • wrong technique in product usage process236
  • fatigue230

Reports by year received

View as table
YearReports
200454
200554
200644
200773
200869
200967
201076
2011100
201296
2013160
2014369
2015909
2016196
2017143
2018385
2019349
2020310
2021410
2022665
2023607
2024651
2025585
2026373

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,047,414 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
hyperglycaemiaSignal32928.425.58,607
hypoglycaemiaSignal43428.125.711,260
blood glucose decreasedSignal29519.317.25,072
blood glucose increasedSignal96616.115.213,685
wrong technique in product usage processSignal2363.63.2452
weight decreasedSignal2422.72.4262
fallSignal2462.32.0183
dyspnoea3311.81.6126
vomiting2371.61.450
diarrhoea3251.61.469
headache2571.31.116
off label use2911.00.90
nausea2501.00.90
fatigue2300.90.82
drug ineffective3800.90.84

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.